Diabetology & Metabolic Syndrome

Scope & Guideline

Unlocking insights for a healthier tomorrow.

Introduction

Delve into the academic richness of Diabetology & Metabolic Syndrome with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN-
PublisherBMC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationDIABETOL METAB SYNDR / Diabetol. Metab. Syndr.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The journal "Diabetology & Metabolic Syndrome" focuses on advancing knowledge in the field of diabetes and its associated metabolic disorders. It aims to publish high-quality research that encompasses various dimensions of diabetes management, including clinical studies, epidemiological investigations, and innovative therapeutic approaches.
  1. Diabetes Management and Treatment Strategies:
    Research on various treatment modalities for diabetes, including pharmacological interventions (like GLP-1 receptor agonists and SGLT2 inhibitors), dietary approaches, and lifestyle modifications aimed at improving glycemic control and managing diabetes-related complications.
  2. Cardiometabolic Health:
    Studies investigating the interrelations between diabetes and cardiovascular diseases, metabolic syndrome, and other comorbidities, focusing on risk factors, outcomes, and management strategies.
  3. Pathophysiology of Diabetes Complications:
    Research into the underlying mechanisms of diabetes-related complications, including nephropathy, retinopathy, neuropathy, and cardiovascular disease, often utilizing molecular, genetic, and epigenetic analyses.
  4. Innovative Diagnostic and Monitoring Technologies:
    Advancements in diabetes monitoring technologies such as continuous glucose monitoring systems, machine learning applications for diabetes risk prediction, and novel biomarkers for early detection of diabetes-related complications.
  5. Public Health and Epidemiology:
    Investigations into the prevalence, risk factors, and socio-economic impacts of diabetes and metabolic syndrome at population levels, aiming to inform public health policies and interventions.
  6. Patient-Centered Care and Education:
    Research focusing on the psychosocial aspects of diabetes, including patient education, self-management strategies, and the impact of mental health on diabetes outcomes.
The journal has recently seen an increase in research themes that reflect evolving challenges and advancements in diabetes care. These emerging areas highlight the dynamic nature of diabetes research and the journal's commitment to staying at the forefront of scientific inquiry.
  1. Molecular Mechanisms and Biomarkers:
    There is a growing emphasis on understanding the molecular mechanisms underlying diabetes and its complications, including the identification of novel biomarkers for early detection and monitoring of diabetes-related conditions.
  2. Impact of Gut Microbiota:
    Research exploring the relationship between gut microbiota and diabetes has gained traction, focusing on how gut health influences metabolic processes, insulin resistance, and overall diabetes management.
  3. Psychosocial and Behavioral Aspects of Diabetes Management:
    Increasing attention is being paid to the psychosocial dimensions of diabetes, including the effects of mental health, stress, and social support on diabetes outcomes, as well as the role of patient education and self-management.
  4. Artificial Intelligence and Digital Health Technologies:
    The integration of artificial intelligence and digital health technologies in diabetes management is an emerging trend, with studies focusing on predictive modeling, telemedicine, and mobile health applications to enhance patient care.
  5. Diabetes in Special Populations:
    Research focusing on diabetes management and outcomes in specific populations, such as children, adolescents, pregnant women, and ethnic minorities, is gaining importance, reflecting the need for tailored approaches in diabetes care.

Declining or Waning

While "Diabetology & Metabolic Syndrome" continues to evolve, certain themes have shown a decline in prominence over recent years. This shift may reflect changes in research priorities, emerging areas of interest, or advancements in understanding diabetes and metabolic disorders.
  1. Traditional Dietary Interventions:
    Research focusing solely on traditional dietary interventions for diabetes management, such as specific diets or food groups, has seen a decline. This shift is likely due to a growing emphasis on personalized nutrition and the role of overall dietary patterns.
  2. Single-Agent Pharmacotherapy Studies:
    The focus on studies investigating single-agent pharmacotherapy for diabetes management has waned. There is now a greater interest in combination therapies and multi-faceted approaches that address the complexity of diabetes.
  3. Basic Science Studies with Limited Clinical Relevance:
    While basic science research remains important, studies that do not translate findings into clinical or practical applications are less prevalent. The journal is increasingly prioritizing research that has direct implications for patient care and outcomes.
  4. Generalized Population Studies:
    Research that broadly examines diabetes prevalence without nuanced analysis of specific populations or subgroups is decreasing. There is a trend towards more targeted studies that consider ethnic, cultural, and socio-economic factors influencing diabetes.

Similar Journals

DIABETES & METABOLISM

Exploring Innovations in Metabolic Health
Publisher: MASSON EDITEURISSN: 1262-3636Frequency: 6 issues/year

DIABETES & METABOLISM, published by MASSON EDITEUR in France, is a leading academic journal dedicated to the fields of endocrinology, diabetes, and metabolism. With an impressive Impact Factor reflecting its esteemed reputation, the journal has been ranked in the Q1 category across multiple disciplines including Endocrinology, Internal Medicine, and more, showcasing its significance and influence in the scientific community. Since its inception in 1996 and continuing its contributions through 2024, DIABETES & METABOLISM systematically disseminates high-quality research findings, reviews, and clinical studies aimed at furthering knowledge and encouraging innovation in metabolic diseases. Although not an open-access journal, it ensures that valuable research is accessible to a broad audience through institutional subscriptions and affiliations. As a key resource for researchers, clinicians, and students alike, this journal stands at the forefront of advancing understanding and treatment options in diabetes and related metabolic disorders, making it an essential addition to any academic library.

ENDOCRINE JOURNAL

Empowering research to unlock hormonal mysteries.
Publisher: JAPAN ENDOCRINE SOCISSN: 0918-8959Frequency: 12 issues/year

ENDOCRINE JOURNAL, published by the Japan Endocrine Society, is a pivotal resource for researchers and professionals in the field of endocrinology, diabetes, and metabolism. With a long history dating back to 1954, this journal encompasses a comprehensive range of topics including hormonal regulation, pathophysiology of endocrine diseases, and innovative therapeutic approaches. Despite its classification as open access, the journal remains a beacon of knowledge, with impressive rankings—Q2 in Endocrinology, Diabetes and Metabolism and Q3 in Endocrinology for 2023—ensuring it is a respected source in the academic community. It serves as a critical platform for the dissemination of cutting-edge research, encouraging collaboration and facilitating advancements in understanding complex endocrine disorders. By subscribing to this journal, researchers and students gain access to seminal studies, clinical insights, and a wealth of information that drives this vital field forward.

BMC Endocrine Disorders

Exploring breakthroughs in endocrine health and disorders.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Endocrine Disorders is a leading open-access journal dedicated to advancing the field of endocrinology, diabetes, and metabolism. Published by BMC since 2001, this journal provides a vibrant platform for researchers to disseminate their findings across a wide array of topics related to endocrine health and disorders. With an impressive Q2 category ranking in both Endocrinology, Diabetes and Metabolism, and Medicine (miscellaneous) for 2023, it has positioned itself among the top-tier journals in its field, reflecting its commitment to high-quality research and discussions. The journal's accessibility enhances its reach and impact, ensuring that important findings are available to all stakeholders in the medical community. Researchers, healthcare professionals, and students alike will find valuable insights and updates that are crucial for both academic and practical applications within this dynamic field. The journal is actively welcoming submissions through 2024, facilitating continuous growth in the scientific discourse surrounding endocrine disorders.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Fostering Collaboration in Endocrinology Research
Publisher: GEORG THIEME VERLAG KGISSN: 0947-7349Frequency: 10 issues/year

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES is a distinguished journal published by GEORG THIEME VERLAG KG, dedicated to advancing research and understanding in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 0947-7349 and an E-ISSN of 1439-3646, this journal serves as a critical platform for disseminating high-quality research findings, reviews, and clinical studies from 1983 to 2024. The journal holds an impactful position within its respective categories, notably achieving Q3 in Endocrinology and Diabetes and Metabolism, and Q2 in Internal Medicine as per the 2023 category quartiles. Additionally, it ranks in the 57th and 46th percentiles in the Scopus rankings for Internal Medicine and Endocrinology, Diabetes and Metabolism, respectively. Though not an open-access publication, the journal caters to a global audience of researchers, professionals, and students, facilitating knowledge exchange and fostering collaboration within this vital area of medical science.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Unveiling breakthroughs in metabolism and diabetes.
Publisher: SPRINGERISSN: 1389-9155Frequency: 6 issues/year

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, published by Springer, is a leading journal in the field of endocrinology, diabetes, and metabolism, with an impressive Q1 ranking in both categories as of 2023. With an ISSN of 1389-9155 and E-ISSN 1573-2606, this journal serves as a vital resource for researchers, clinicians, and students seeking comprehensive reviews that address the latest advancements and interdisciplinary approaches in the management of endocrine and metabolic disorders. Operating from the Netherlands, it features articles that are rigorously peer-reviewed and is notable for its significant impact factor reflected in its Scopus rankings, placing it in the top percentile of its categories. Although it does not currently offer open access, it provides critical insights applicable to both basic and clinical settings, making it indispensable for those dedicated to enhancing patient outcomes in endocrine health.

DIABETES CARE

Leading the way in diabetes research excellence.
Publisher: AMER DIABETES ASSOCISSN: 0149-5992Frequency: 12 issues/year

DIABETES CARE, published by the American Diabetes Association, is a premier journal dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Since its inception in 1978, this journal has maintained a commitment to disseminating high-quality research, evidenced by its prestigious ranking in the Q1 category across multiple fields including Advanced and Specialized Nursing, Endocrinology, Diabetes and Metabolism, and Internal Medicine. With an impressive impact factor and distinguished Scopus rankings, DIABETES CARE serves as an essential resource for researchers, clinicians, and students alike, facilitating the exchange of knowledge and fostering innovation in diabetes care. Although not an open-access publication, the journal offers various ways to access groundbreaking studies and advancements in the field. This commitment to excellence reflects the journal's vital role in shaping diabetes research and clinical practices globally.

HORMONE AND METABOLIC RESEARCH

Unraveling the Complexities of Hormonal Influence
Publisher: GEORG THIEME VERLAG KGISSN: 0018-5043Frequency: 12 issues/year

HORMONE AND METABOLIC RESEARCH, published by GEORG THIEME VERLAG KG, stands as a reputable platform in the fields of biochemistry, endocrinology, and metabolism since its establishment in 1969. This peer-reviewed journal provides critical insights and advancements in the intricate relationships between hormones and metabolic processes, catering to researchers, healthcare professionals, and students alike. With an impressive convergence of knowledge spanning over five decades, it maintains a commendable Q3 ranking in multiple categories, including Biochemistry, Clinical Biochemistry, and Endocrinology, highlighting its contribution to cutting-edge scientific discourse. Although not an open-access journal, it offers a plethora of access options for readers and institutions, ensuring that vital research reaches those who need it most. Located in Stuttgart, Germany, the journal is positioned at the forefront of influential research in hormone and metabolic studies, emphasizing its importance for ongoing investigations into health and disease.

DIABETES OBESITY & METABOLISM

Elevating the discourse on metabolic disorders worldwide.
Publisher: WILEYISSN: 1462-8902Frequency: 12 issues/year

DIABETES OBESITY & METABOLISM, published by Wiley, is a premier international journal dedicated to the fields of endocrinology, diabetes, and metabolic disorders. With an impressive impact factor and its status as a Q1 journal in multiple categories—including Endocrinology and Internal Medicine—this publication is highly regarded in the academic community. Since its inception in 1999, the journal has served as a crucial platform for the dissemination of cutting-edge research, reviews, and clinical studies, driving advancements in understanding and treatment of diabetes and obesity. Researchers and professionals alike benefit from its rigorous peer-review process and extensive reach, as it aims to bridge the gap between laboratory findings and clinical applications. Although not an Open Access journal, articles are accessible through institutional subscriptions, ensuring that vital knowledge reaches those committed to enhancing patient care and expanding the scientific body of work in these pivotal areas.

Journal of the ASEAN Federation of Endocrine Societies

Connecting Minds: Fostering Endocrine Research Across Borders
Publisher: ASEAN FEDERATION ENDOCRINE SOCISSN: 0857-1074Frequency: 2 issues/year

Welcome to the Journal of the ASEAN Federation of Endocrine Societies, a pioneering publication dedicated to advancing knowledge and research in the fields of Endocrinology, Diabetes, and Metabolism. Established by the ASEAN Federation Endocrine Society and open access since 2011, this journal enhances the dissemination of critical findings and encourages collaboration among professionals and researchers across Southeast Asia and beyond. With an ISSN of 0857-1074 and E-ISSN of 2308-118X, the journal is indexed within Quartile 4 in the 2023 rankings of its categories, reflecting its commitment to providing a platform for scholarly work despite its emerging status. Situated in the Philippines, the journal focuses on the latest trends, treatments, and innovative research approaches in endocrinology, making it an essential resource for academics, clinicians, and students alike. We invite you to explore our content and contribute to advancing the endocrine sciences.

TRENDS IN ENDOCRINOLOGY AND METABOLISM

Transforming understanding of metabolism and disease.
Publisher: CELL PRESSISSN: 1043-2760Frequency: 12 issues/year

TRENDS IN ENDOCRINOLOGY AND METABOLISM, published by CELL PRESS, stands as a pivotal resource in the fields of endocrinology, diabetes, and metabolism. With its ISSN 1043-2760 and E-ISSN 1879-3061, this esteemed journal has been a leading platform since its inception in 1989, currently projected to span until 2024. Recognized within the top quartile (Q1) of its category, it boasts impressive Scopus rankings, holding the 4th position in Endocrinology and 8th in Endocrinology, Diabetes, and Metabolism. These rankings underscore its significant impact, evidenced by an impressive percentile rank of 97th and 96th respectively. The journal is committed to facilitating the dissemination of cutting-edge research and innovative insights, making it an essential read for researchers, clinicians, and students seeking to stay informed on the latest advancements in these critical fields. With a robust focus on providing thorough reviews and original research articles, TRENDS IN ENDOCRINOLOGY AND METABOLISM continues to shape the understanding and treatment of metabolic disorders.